Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Datta, Kamal ^a,b   Hyduke, Daniel R ^a   Suman, Shubhankar ^a   Moon, Bo Hyun ^a   Johnson, Michael D ^b   Fornace Jr, Albert J ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Gene expression; Mouse mammary gland; Persistent microarray changes.; Radiation exposure

Indexed keywords

CYCLIN DEPENDENT KINASE 5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 12; PROTEIN 14 3 3; STATHMIN; TRANSCRIPTION FACTOR E2F6; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GAMMA RADIATION; GENE; GENE EXPRESSION; IONIZING RADIATION; MAMMARY GLAND; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; SIGNAL TRANSDUCTION; UPREGULATION; WHOLE BODY RADIATION;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; NEOPLASMS, RADIATION-INDUCED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION, IONIZING; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84870378499     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-205     Document Type: Article

References (69)

1. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005, 7:21-32. 10.1186/bcr970, 1064116, 15642178.
2. Shuryak I, Sachs RK, Brenner DJ. Cancer risks after radiation exposure in middle age. J Natl Cancer Inst 2010, 102:1628-1636. 10.1093/jnci/djq346, 2970575, 20975037.
3. Brenner DJ, Hricak H. Radiation exposure from medical imaging: time to regulate. JAMA 2010, 304:208-209. 10.1001/jama.2010.973, 20628137.
4. Boice JDJ, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992, 326:781-785. 10.1056/NEJM199203193261201, 1538720.
5. Snyder AR, Morgan WF. Gene expression profiling after irradiation: clues to understanding acute and persistent responses. Cancer Metastasis Rev 2004, 23:259-268.
6. Prolla TA. DNA microarray analysis of the aging brain. Chem Senses 2002, 27:299-306. 10.1093/chemse/27.3.299, 11923192.
7. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 1995, 57:289-300.
8. Gupta RK, Arany Z, Seale P, Mepani RJ, Ye L, Conroe HM, Roby YA, Kulaga H, Reed RR, Spiegelman BM. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464:619-623. 10.1038/nature08816, 2845731, 20200519.
9. Gubelmann C, Gattiker A, Massouras A, Hens K, David F, Decouttere F, Rougemont J, Deplancke B. GETPrime: a gene- or transcript-specific primer database for quantitative real-time PCR. Database (Oxford) 2011, 2011:bar040.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
11. Bernardi C, Ribeiro C, Ede S, Cavalli IJ, Chautard-Freire-Maia EA, Souza RL. Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer. Cancer Genet Cytogenet 2010, 197:158-165. 10.1016/j.cancergencyto.2009.10.011, 20193849.
12. Zajac M, Gomez G, Benitez J, Martinez-Delgado B. Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer. BMC Med Genomics 2010, 3:44. 10.1186/1755-8794-3-44, 2959047, 20920318.
13. Ishiwata T, Matsuda Y, Naito Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 2011, 17:409-418. 10.3748/wjg.v17.i4.409, 3027007, 21274370.
14. Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol 2011, 338:28-37. 10.1016/j.mce.2011.02.014, 21356271.
15. Sala G, Dituri F, Raimondi C, Previdi S, Maffucci T, Mazzoletti M, Rossi C, Iezzi M, Lattanzio R, Piantelli M, et al. Phospholipase Cgamma1 is required for metastasis development and progression. Cancer Res 2008, 68:10187-10196. 10.1158/0008-5472.CAN-08-1181, 19074886.
16. Wirtenberger M, Tchatchou S, Hemminki K, Schmutzhard J, Sutter C, Schmutzler RK, Meindl A, Wappenschmidt B, Kiechle M, Arnold N, et al. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 2006, 27:2201-2208. 10.1093/carcin/bgl067, 16704985.
17. Belguise K, Sonenshein GE. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. J Clin Invest 2007, 117:4009-4021. 2082145, 18037997.
18. Bhat HF, Baba RA, Bashir M, Saeed S, Kirmani D, Wani MM, Wani NA, Wani KA, Khanday FA. Alpha-1-syntrophin protein is differentially expressed in human cancers. Biomarkers 2011, 16:31-36. 10.3109/1354750X.2010.522731, 21091386.
19. Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG, Ficarra G, Federico M, Iannone A. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients. J Proteome Res 2009, 8:4916-4933. 10.1021/pr900239h, 19739612.
20. Garcia-Marcos M, Ghosh P, Farquhar MG. Molecular basis of a novel oncogenic mutation in GNAO1. Oncogene 2011, 30:2691-2696. 10.1038/onc.2010.645, 3349449, 21317923.
21. Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Lkpatt F, et al. A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med 2009, 7:9. 10.1186/1741-7015-7-9, 2671523, 19291283.
22. Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010, 9:2412-2422. 10.4161/cc.9.12.11989, 20562527.
23. Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway. Breast Cancer Res 2005, 7:R82-92. 10.1186/bcr954, 1064102, 15642172.
24. Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, Aaronson SA, Lee SW. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem 1999, 274:11022-11029. 10.1074/jbc.274.16.11022, 10196184.
25. Oberley MJ, Inman DR, Farnham PJ. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J Biol Chem 2003, 278:42466-42476. 10.1074/jbc.M307733200, 12909625.
26. Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S. Estrogen-related receptor gamma modulates cell proliferation and estrogen signaling in breast cancer. J Steroid Biochem Mol Biol 2011, 123:1-7. 10.1016/j.jsbmb.2010.09.002, 20883782.
27. Rosenthal DT, Iyer H, Escudero S, Bao L, Wu Z, Ventura AC, Kleer CG, Arruda EM, Garikipati K, Merajver SD. p38gamma promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Res 2011, 71:6338-6349. 10.1158/0008-5472.CAN-11-1291, 3193559, 21862636.
28. Shehu A, Albarracin C, Devi YS, Luther K, Halperin J, Le J, Mao J, Duan RW, Frasor J, Gibori G. The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells. Mol Endocrinol 2011, 25:754-766. 10.1210/me.2010-0261, 3082328, 21372145.
29. Cheng S, Douglas-Jones A, Yang X, Mansel RE, Jiang WG. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance. Cancer Genomics Proteomics 2010, 7:67-73.
30. Germain DR, Graham K, Glubrecht DD, Hugh JC, Mackey JR, Godbout R. DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat 2011, 127:53-63. 10.1007/s10549-010-0943-7, 20499159.
31. Alhopuro P, Karhu A, Winqvist R, Waltering K, Visakorpi T, Aaltonen LA. Somatic mutation analysis of MYH11 in breast and prostate cancer. BMC Cancer 2008, 8:263. 10.1186/1471-2407-8-263, 2562392, 18796164.
32. Ayyasamy V, Owens KM, Desouki MM, Liang P, Bakin A, Thangaraj K, Buchsbaum DJ, LoBuglio AF, Singh KK. Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin. PLoS One 2011, 6:e24792. 10.1371/journal.pone.0024792, 3174207, 21935467.
33. Sharp JA, Mailer SL, Thomson PC, Lefevre C, Nicholas KR, Sharp JA, Mailer SL, Thomson PC, Lefevre C, Nicholas KR. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line. Mol Cancer 2008, 7:1. 2263075, 18179684.
34. Ma S, Kosorok MR. Detection of gene pathways with predictive power for breast cancer prognosis. BMC Bioinformatics 2010, 11:1. 10.1186/1471-2105-11-1, 2837025, 20043860.
35. Haakensen VD, Bjoro T, Luders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Borresen-Dale AL, Helland A. Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas. BMC Cancer 2011, 11:332. 10.1186/1471-2407-11-332, 3163631, 21812955.
36. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 2008, 68:3178-3184. 10.1158/0008-5472.CAN-08-0533, 2685173, 18451143.
37. Stender JD, Stossi F, Funk CC, Charn TH, Barnett DH, Katzenellenbogen BS. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Mol Endocrinol 2011, 25:1699-1709. 10.1210/me.2011-0102, 3182422, 21868451.
38. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clin Cancer Res 2005, 11:4357-4364. 10.1158/1078-0432.CCR-04-2107, 15958618.
39. Naderi A, Meyer M, Dowhan DH. Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. Neoplasia 2012, 14:283-296. 3349255, 22577344.
40. Nishida K, Tsukamoto T, Uchida K, Takahashi T, Takahashi T, Ueda R. Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7. Anticancer Res 1996, 16:3397-3402.
41. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res 2010, 16:681-690. 10.1158/1078-0432.CCR-09-1091, 2892225, 20068102.
42. Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am J Pathol 2005, 167:585-597. 10.1016/S0002-9440(10)63000-3, 1603555, 16049342.
43. Hu Y, Sun H, Drake J, Kittrell F, Abba MC, Deng L, Gaddis S, Sahin A, Baggerly K, Medina D, Aldaz CM. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 2004, 64:7748-7755. 10.1158/0008-5472.CAN-04-1827, 15520179.
44. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One 2010, 5:e9201. 10.1371/journal.pone.0009201, 2821407, 20169162.
45. Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN, Mori De Santiago M, Fernandez Perez L. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 2009, 22:1425-1433.
46. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
47. Whitaker-Menezes D, Martinez-Outschoorn UE Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Pavlides S, Tsirigos A, Ertel A, Pestell RG, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: Visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011, 10:4047-4064. 10.4161/cc.10.23.18151, 3272287, 22134189.
48. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32. 10.1016/j.ccr.2004.06.010, 15261139.
49. Huang M, Li Y, Zhang H, Nan F. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction. J Exp Clin Cancer Res 2010, 29:80. 10.1186/1756-9966-29-80, 2911413, 20569497.
50. Suman S, Johnson MD, Fornace AJJ, Datta K. Exposure to Ionizing Radiation Causes Long-Term Increase in Serum Estradiol and Activation of PI3K-Akt Signaling Pathway in Mouse Mammary Gland. Int J Radiat Oncol Biol Phys 2012, 84:500-507. 10.1016/j.ijrobp.2011.12.033, 22381906.
51. Higgins GC, Beart PM, Nagley P. Oxidative stress triggers neuronal caspase-independent death: endonuclease G involvement in programmed cell death-type III. Cell Mol Life Sci 2009, 66:2773-2787. 10.1007/s00018-009-0079-2, 19582370.
52. Haynes BP, Straume AH, Geisler J, A'Hern R, Helle H, Smith IE, Lonning PE, Dowsett M. Intratumoral estrogen disposition in breast cancer. Clin Cancer Res 2010, 16:1790-1801. 10.1158/1078-0432.CCR-09-2481, 20215536.
53. Abdulkadir SA, Carbone JM, Naughton CK, Humphrey PA, Catalona WJ, Milbrandt J. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol 2001, 32:935-939. 10.1053/hupa.2001.27102, 11567222.
54. Kadara H, Fujimoto J, Men T, Ye X, Lotan D, Lee JS, Lotan R. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas. Neoplasia 2010, 12:499-505. 2887090, 20563252.
55. Soong J, Chen Y, Shustef EM, Scott GA. Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth. J Invest Dermatol 2012, 132:1230-1238. 10.1038/jid.2011.414, 3305852, 22189792.
56. Veeramani S, Yuan TC, Chen SJ, Lin FF, Petersen JE, Shaheduzzaman S, Srivastava S, MacDonald RG, Lin MF. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. Endocr Relat Cancer 2005, 12:805-822. 10.1677/erc.1.00950, 16322323.
57. Song Z, He CD, Sun C, Xu Y, Jin X, Zhang Y, Xiao T, Wang Y, Lu P, Jiang Y, et al. Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivo. Exp Dermatol 2010, 19:958-964. 10.1111/j.1600-0625.2009.01020.x, 20100193.
58. Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M. Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 2003, 22:538-547. 10.1038/sj.onc.1206141, 12555067.
59. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 2003, 12:1087-1099. 10.1016/S1097-2765(03)00424-6, 14636569.
60. Shostak K, Chariot A. NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 2011, 13:214. 10.1186/bcr2886, 3236328, 21867572.
61. Liu W, Bagaitkar J, Watabe K. Roles of AKT signal in breast cancer. Front Biosci 2007, 12:4011-4019. 10.2741/2367, 17485354.
62. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC. The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 2005, 1(12):S37-46.
63. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
64. Mantovani A, Marchesi F, Porta C, Sica A, Allavena P. Inflammation and cancer: breast cancer as a prototype. Breast 2007, 2(16):S27-33.
65. Powell BL, Piersma D, Kevenaar ME, van Staveren IL, Themmen AP, Iacopetta BJ, Berns EM. Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset. J Clin Endocrinol Metab 2003, 88:1653-1657. 10.1210/jc.2002-021585, 12679452.
66. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15:17-35.
67. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 2007, 67:11517-11527. 10.1158/0008-5472.CAN-07-1284, 18089780.
68. Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006, 36(Suppl 2):121-125. 2663653, 16862418.
69. Mettler FAJ, Voelz GL. Major radiation exposure--what to expect and how to respond. N Engl J Med 2002, 346:1554-1561. 10.1056/NEJMra000365, 12015396.